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The abnormal inﬂammatory responses due to the lung tissue damage and ineﬀective repair/resolution in response to the inhaled toxicants result in the pathological changes associated with chronic respiratory diseases.
Investigation of such pathophysiological mechanisms provides the opportunity to develop the molecular phenotype-speciﬁc diagnostic assays and could help in designing the personalized medicine-based therapeutic approaches against these prevalent diseases. As the central hubs of cell metabolism and energetics, mitochondria
integrate cellular responses and interorganellar signaling pathways to maintain cellular and extracellular redox
status and the cellular senescence that dictate the lung tissue responses. Speciﬁcally, as observed in chronic
obstructive pulmonary disease (COPD) and pulmonary ﬁbrosis, the mitochondria-endoplasmic reticulum (ER)
crosstalk is disrupted by the inhaled toxicants such as the combustible and emerging electronic nicotine-delivery
system (ENDS) tobacco products. Thus, the recent research eﬀorts have focused on understanding how the
mitochondria-ER dysfunctions and oxidative stress responses can be targeted to improve inﬂammatory and
cellular dysfunctions associated with these pathologic illnesses that are exacerbated by viral infections. The
present review assesses the importance of these redox signaling and cellular senescence pathways that describe
the role of mitochondria and ER on the development and function of lung epithelial responses, highlighting the
cause and eﬀect associations that reﬂect the disease pathogenesis and possible intervention strategies.

1. Introduction
The environmental toxicants, such as ambient particulate matter,
tobacco smoke, biomass fuel smoke, vapors from electronic cigarettes
(e-cig) or ozone, are highly oxidizing in nature and cause lung injury by
oxidative stress. Mitochondria are the major cellular oxidative stress
sensors that regulate metabolism, signaling, and energetics to maintain
cellular and tissue homeostasis. In addition, mitochondria are reportedly critical in regulating cellular inﬂammatory responses, innate
immunity, and aging [1–4]. The mitochondrial dysfunction and the
dysregulated reactive oxygen species (ROS) production following lung
inﬂammation contributes to various lung diseases and impaired lung
functions. At the same time, the protein folding in the endoplasmic
reticulum (ER) is susceptible to extracellular stimuli and insults. ER is a
highly organized luminal network that plays an important role in protein synthesis, maturation, folding and transport. ER is also the central
site for Ca++ storage and homeostasis and regulates cellular redox

status and energy stores because this organelle is also the site for lipid,
cholesterol, and steroid biosynthesis, and asparagine-linked protein
glycosylation [5–9]. The ER couples its quality control machinery to
Ca++ and any alterations in intraluminal Ca++ by extra- or intra-cellular factors can cause protein misfolding. Accordingly, when ER
homeostasis is disrupted by the inhaled toxicants, the ER develops an
unfolded protein response (UPR) in order to maintain cellular homeostasis [5–7]. However, a dysregulated homeostasis following the unresolved stress in mitochondria and ER can initiate cell death pathways.
Studies have shown that various signaling pathways, triggered by the
UPR and ROS, are crucial to trigger cell death/apoptosis when they fail
to restore protein homeostasis and survival [8].
Recent seminal studies have provided in-depth mechanistic insights
into how the chronic and acute lung injury disrupts the mitochondrial
activity and ER homeostasis that triggers an unresolvable UPR activation, disrupts cellular metabolism/energetics, and causing uncontrolled
cell death. Cigarette smoke (CS) and their related products are the
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ER stress in the lung can occur due to heightened physiological
(secretory load) and pathological stress (oxidative stress, CS exposure,
hypoxia, starvation, altered calcium levels, and viral infection) that
results in increased protein inﬂux, and accumulation of unfolded proteins in the ER lumen. Previous studies have shown that CS-induced ER
stress in the lungs of smokers and patients with COPD via oxidant-induced irreversible damage of lung proteins via the ubiquitin-proteasome system or autophagic vacuoles [11,21]. ER in lung ﬁbroblasts
from patients with COPD shows more disorganized dots and patchy
structure compared to the more reticulated structure observed in neversmokers and ever-smokers [22]. CS-induced increase in poly-ubiquitination of proteins in diﬀerent lung cell types, in vitro in alveolar and
airway epithelial cells, lung ﬁbroblasts and alveolar macrophages, and
in vivo in mouse lungs [11,21,23–25]. This supports that CS-induced
increase in misfolded proteins in the ER and impairs the ER folding
capacity. Chronic CS upregulated protein abundance of the chaperones,
glucose-regulated protein of 78 kDa (GRP78), calnexin, and calreticulin, protein disulﬁde isomerase (PDI) and other signaling molecules
that play a vital role in the PERK pathway (phosphorylated-eIF2a,
ATF4, and CHOP) in the human lung [10,25–27]. Additional evidence
from a mouse model of CS exposure demonstrates increased expression
of phospho-eIF2α, CHOP, and p50 ATF6N protein abundance and
mRNA levels in mouse lung [11]. Acute vs. chronic CS exposure in
mouse showed diﬀerences in mRNA levels of ATF4 and CHOP in mouse
lungs and alveolar macrophages, suggesting that UPR target genes and
proteins at the transcriptional and translational levels are dynamic and
cell type-dependent in vivo [23,28,29]. GRP78 is an ER chaperone
known to be involved in alveolar epithelial cell survival and gene expression during lung development via modulation of ER stress [30–32].
Previous reports have shown increased GRP78 protein levels in the
lungs of smokers and patients with COPD. Furthermore, GRP78 serum
levels were signiﬁcantly increased in COPD that correlated with decline
in lung function and severity of disease (emphysema) [33]. In another
report, BALF levels of GRP78 were signiﬁcantly greater in smokers
compared to non-smokers and human airway epithelial cells treated
with CS extract showed augmented secretion of GRP78 [26]. Overall,
these ﬁndings on elevated ER stress protein GRP78 levels could be a
potential biomarker for CS-induced lung injury and chronic lung diseases.
Surprisingly, COPD patients that were stable along with varying
range of disease severity and diaphragm muscle weakness, when analyzed for markers of ER stress/UPR signal mediators (markers of protein
misfolding, proteolysis, apoptosis including ATF6, PERK and IRE1
pathways) showed no signiﬁcant alterations in main respiratory muscle
both at the mRNA and protein levels [34]. These ﬁndings from stable
COPD patients with diaphragm muscle dysfunction and associated severe airﬂow limitation did not correlate with the status of ER stress and
UPR [34]. Hence, therapeutic strategies using ER stress inhibitors or
UPR modulators to treat diaphragm muscle dysfunction in COPD patients with advanced disease may not be advisable. A recent report by
Aggarwal et al. (2018) reported augmented heme and ER stress marker,
GRP78/BIP, in the plasma of very severe (GOLD 4) COPD patients [35].
These ﬁndings corroborated with the increase in plasma heme levels of
ferrets exposed to chronic CS (6 months) and in mice exposed to bromine (Br2) gas at 400 ppm for 30 min/day for 14–21 days [35]. Although all branches of the UPR in some way regulate CHOP [36], the
ATF4 was established as a major CHOP inducer in the ATF4 haplodeﬁcient (ATF4+/−) mice model of Br2 exposure [35]. The mice exposed
to Br2 show elevated plasma heme levels resulting in increased ER stress
markers such as GRP78, phospho-PERK, pIRE1α, ATF4, ATF6 and
CHOP associated with other lung pathological manifestations such as
airway enlargement and increased lung compliance that resembles
pulmonary ﬁbrosis and emphysema observed in humans [35]. Additionally, attenuation of ER stress using salubrinal (ER stress inhibitor;
1 mg/kg BW), a heme scavenger, abrogates levels/activity of elastase,
reduces the inﬂammatory response (neutrophils and macrophages) and

major risk factors of respiratory diseases like chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary ﬁbrosis (IPF) because CS exposure results in aggregation of oxidative stress-mediated
misfolded/unfolded proteins in the lung epithelium [10]. Other than CS
exposure, dysregulation in mitophagy, aging, cellular senescence, viral
infections, and disruption in cellular circadian rhythms are associated
with the development of COPD and ﬁbrosis. Increasing evidence suggests that ER stress and impaired elimination of damaged protein via
UPR may play a role in the pathogenesis of COPD [11–13]. In this review, we elaborately discuss the etiological risk factors of COPD as well
as the CS-induced oxidative stress, mitochondrial dysfunction, circadian rhythm, aging and cellular senescence mediated ER stress responses. Although the primary focus of this paper is on the cellular
stress response in COPD, it is important to acknowledge that there is in
fact strong phenotypic similarity between COPD and IPF. Both are
characterized by increased and accelerated pulmonary cellular senescence and compromised regenerative potential often induced by fulminating oxidative damage associated with the chronic cigarette smoke
exposure [14,15]. As such, when addressing the cellular and redox
stress response, some molecular aspects of IPF are also discussed. Additionally, some recent developments that illustrate how targeting the
speciﬁc ER-mitochondria redox signaling events may be more beneﬁcial in managing chronic lung disease.
1.1. Mitochondrial dysfunction and mitophagy
Damaged or dysfunctional mitochondria are normally cleared from
the cell by mitophagy, whereby defective mitochondria are loaded into
the autophagosomes, followed by lysosomal degradation. Mitophagy is
activated by mitochondrial membrane depolarization followed by stabilization of Pink1 (PTEN-induced putative kinase 1) on mitochondrial
outer membranes, which are involved in mitochondrial quality control
through ﬁssion [16]. Pink1 then recruits an E3 ubiquitin ligase called
Parkin (a protein involved in mitochondrial quality control), from the
cytosol [17]. Once recruited to mitochondria, Parkin leads to degradation of mitofusin2 (Mfn2, a core protein involved in mitochondrial fusion), which initiates localization of damaged mitochondria
with the isolation membranes containing protein microtubule-associated protein light chain 3 (LC3) and formation of autophagosome,
where damaged mitochondria are degraded to maintain mitochondrial
homeostasis [18]. Pink1 and Parkin knockout (KO) mice exhibit increased ROS levels and dysfunctional mitochondria [19], suggesting
that these proteins may play a critical role in cellular senescence [20].
Conversely, Parkin overexpression increases life span in fruit ﬂies,
partly due to a reduction in oxidative stress that is mitigated by active
mitophagy.
1.2. Mitochondria-ER dysfunctions and ER stress responses in COPD
ER stress occurs when the rate at which new protein entering the ER
exceeds its folding capacity within the ER and the cells undergo
adaptive UPR to defend against ER stress [7]. The UPR is comprised of a
series of transcriptional, translational, and post-translational processes
that can lower the rate of protein synthesis and increase the protein
folding capacity of the ER machinery, enhancing the process of misfolded protein elimination, and escalating the size of the ER compartment thereby reducing the ER stress. Prior studies have shown that
various signaling pathways triggered by UPR are crucial within the cells
either to trigger cell death/apoptosis when it is unable to restore protein homeostasis and survival [8]. Evidence suggest that UPR is among
the key players that could cause lung disease via altered expression of
genes and misfolded proteins [9]. UPR restores protein homeostasis via
triggering intracellular signal transduction of ER transmembrane proteins such as protein kinase RNA (PKR)-like ER kinase (PERK), activating transcription factor-6 (ATF6), and inositol-requiring enzyme 1
alpha (IRE1α) [7].
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ER and mitochondrial therapeutic targets in chronic pulmonary diseases associated with CS exposure.
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Fig. 1. Potential therapeutic targets within the unfolded protein response pathways that are involved in chronic airway diseases.

lung ﬁbrotic and emphysematous pathophysiological phenotypes
caused by Br2 exposure wild-type and ATF4+/− mice [35].
A previous report showed chlorine gas exposure in mice enhanced
the expression of UPR marker p-PERK levels in the lungs and skin (as
early as 1–6 h) [37]. Other evidence from literature demonstrates
human neutrophil elastase induces UPR by activating PERK-CHOP
signaling mediated apoptosis in endothelial cells [38]. Gaseous exposure induced inhalation injury can result in heme-dependent airway
damage that might contribute to lung ﬁbrotic and emphysematous
changes. These ﬁndings support that heme could be a potential culprit
associated with silica, quartz and cadmium induced lung injury caused
due to environmental exposures. Therapeutic approaches to treat such
inhalation injury induced heme levels using heme-scavenging protein
(Hx), albumin and haptoglobin along with pharmacological ER stress
blockers may be beneﬁcial. Overall, these ﬁndings suggest that ERstress related UPR pathways are essential for normal cellular functions
(Table 1) and any disruption in their function can cause pathological
changes leading to disease conditions. Thus, these molecular pathways
could be potential therapeutic targets against CS-induced lung injury
and chronic lung diseases, as outlined in Fig. 1. However, one must be
wary when considering UPR components as potential therapeutic targets, as there is often intra- and inter-pathway cross linking, and certain
UPR components may interact with others, as well as with other cellular
pathways and responses. Furthermore, although the UPR seems to induce various pathologic changes in chronic pulmonary disease, it also
induces increased antioxidant expression. Speciﬁcally, the PERK/
eIF2α/CHOP branch of the UPR has been shown to drive the expression
of nuclear factor (erythroid 2)-related factor 2 or Nrf2 [10,36]. In turn,
Nrf2 interacts with ATF4 and together they drive the expression of
genes involved in glutathione synthesis, hydrogen peroxide scavenging
and more [39]. Furthermore, the PERK/eIF2α branch is signiﬁcantly
involved in cell fate decisions by inducing, or preventing apoptosis,
particularly upon chronic ER stress. Speciﬁcally, Kasai et al. (2019)
have shown that when Nrf2 interacts with ATF4, they repress the expression of CHOP, a proapoptotic gene [40,41]. The Ire1 branch has
also been implicated in proapoptotic induction via the regulated Ire1dependent decay pathway (RIDD) and all three branches (ATF6, ATF4
and XBP1) can potentially bind CHOP [42,43]. As such, excessive

inhibition of the UPR, speciﬁcally of the PERK branch may have deleterious eﬀects and as such further research is required. Whilst, Nrf3 has
a crucial role in smooth muscle cells and was involved in the ER-stress
induced diﬀerentiation [44].

1.3. Circadian clock and ER stress crosstalk in relevance with ER and
mitochondria stress in lung diseases
The circadian clock is a self-sustained system of biological oscillations with a period near 24 h that are driven by the circadian timing in
mammals [45]. Circadian clock at the cellular level consist of transcription-translation feedback loop of transcriptional regulators called
clock genes. The circadian clock molecule BMAL1:CLOCK drives the
expression of the repressors PER (period) and CRY (cryptochrome)
genes. PER and CRY genes following a series of post-translational
modiﬁcations repress their own expression by blocking the activity of
BMAL1:CLOCK [45]. The detailed molecular circadian clock mechanisms involved in lung pathophysiology have been extensively reviewed
previously [46]. Based on the recent reports on circadian clock and UPR
in cancer biology and ﬁbrosis [47,48], it will be important to turn our
attention towards the role of the circadian clock-ER stress axis in
chronic inﬂammatory lung diseases. Studies that directly support the
involvement of circadian clock and ER stress interactions are sparse.
Clock disruption has been associated with lung immune-inﬂammatory disorders such as COPD asthma, lung cancers, metabolic
diseases, and aging [46,49–52]. Understanding the novel interactions
and molecular connections that occur between the circadian clock and
cellular processes such as the UPR in the context of normal vs. diseased
pathophysiology will provide better drug targets for chronotherapeutics
of ER-stress induced chronic lung diseases. The ER is one of the other
intracellular organelles that display diurnal rhythmicity in their structural proteins, functions, and response to speciﬁc stressors [53]. A
previous report has demonstrated that secretory pathways that include
ribosomes, ER chaperones, Golgi vesicles display rhythmic oscillations
similar to those observed in liver secretions [54]. Binding immunoglobulin protein (BiP) is known for its control of URP activation
during ER stress [55]. Recently, the link between ER stress and circadian rhythm in ﬁbroblasts and mouse that actively secreting collagen
4
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chronic lung diseases.

(low during the day and high during the night) was extensively investigated [48,56,57]. A previous study showed levels of extractable
collagen-I oscillates with a 24 h period but not the transcript levels of
collagen-I polypeptide chains. Hence, the circadian rhythmicity of extracellular collagen observed could be generated post-transcriptionally
[57]. Additional evidence suggests that BiP overexpression or treatment
with chemical chaperons strengthens circadian rhythm (amplitude of
oscillation) in immortalized tail tendon ﬁbroblasts [48]. ER stress is one
among the active players involved in the pathogenesis of pulmonary
ﬁbrosis [58]. Based on the abovementioned evidence that ER stress
activation could dampen circadian rhythms and collagen synthesis,
understanding the mechanism by which lung ﬁbroblasts circumvent
this physiological control can provide novel drug targets to treat ﬁbrotic lung disease.
Previous reports have evidently shown that ATF4 is a transcriptional
regulator of CLOCK and XBP1 splicing by IRE1α follows a 12 h rhythm
coordinated by the clock machinery [59,60]. In a recent report, XBP1
regulated the cell-autonomous mammalian 12 h clock independent of
the circadian clock to coordinate metabolic and stress rhythms in the
ER and mitochondria across species such as nematodes, crustacean, and
mammals [61]. Increased XBP1 mRNA splicing via IRE1α-dependent
mechanism show reduced Per1 expression in glioblastoma cells [62].
Another report showed ATF4-mediated rhythmic expression of Per2
gene sustains circadian oscillators via cAMP-dependent signaling using
in vitro (mouse embryonic ﬁbroblasts) and in vivo (ATF4-null mice)
models [60]. Hence, understanding the novel interactions between the
ER stress-mediated UPR and circadian clock molecules in normal vs.
diseased state will be essential to reduce time-of-day dependent proteotoxicity.
Recently, miR-211 coordination of UPR and circadian clock
(CLOCK:BMAL1) during cell survival and tumor progression was demonstrated [47]. An earlier report showed that miR-211 is induced as a
result of ER stress possibly via the PERK-eIF2α-ATF4 axis dependent
mechanism [63]. Compelling evidence on the UPR-miR-211-clock axis
comes from oncogene-induced ER stress and associated PERK activation
in tumor cells (c-Myc+) with increased miR-211 and decreased BMAL1
expression [47]. Blocking PERK or miR-211 in cancer cells restored
BMAL1 expression and its downstream signaling targets [47]. Melatonin is an indoleamine hormone secreted by the pineal gland that has
been shown to regulate circadian rhythms [64]. Additional evidence
suggest that melatonin exhibits protective eﬀects against a variety of
inﬂammatory disorders that aﬀect the cardiovascular and pulmonary
systems. Previously, melatonin levels were signiﬁcantly lower in patients with acute COPD exacerbation compared to stable COPD [65].
Melatonin administration in patients with COPD show reduced oxidative stress and improved dyspnea despite no signiﬁcant change in lung
function and their exercise capacity [66]. Melatonin treatment in mice
exposed to CS and lipopolysaccharide (LPS) showed protection against
ﬁbrotic responses by downregulating TGF-β1, collagen I, and SMAD3.
In a recent report, male Wistar rats challenged with CS and LPS to induce COPD when treated with melatonin shows attenuation of COPD
development by activating sirtuin-1 (SIRT-1) expression thereby reducing apoptosis and ER stress in the lung [67,68]. The circadian clock
has also been investigated in IPF. Recently, Cunningham et al. have
presented the core clock protein Rev-Erbα as an important player in
epithelial-mesenchymal transition. They found that Rev-Erbα leads to
dysregulation of the integrinβ1 adhesion formation and increased
myoﬁbroblast activation, suggesting it as a viable therapeutic target for
IPF [69]. Melatonin may have a therapeutic role in IPF as well as
Sanchez et al. (2018) have shown that mice treated with melatonin
have a reduced amount of both Rev-Erbα as well as GRP78 [70]. Research on the permissive or causative role of molecular clock dysfunction-ER cross-talks that constantly occur in chronic inﬂammatory lung
diseases is required. Collectively, these ﬁndings support the fact that
circadian clock and ER stress/UPR are tightly regulated molecular
signaling pathways that can be signiﬁcantly altered contributing to

1.4. Combustible and electronic cigarettes in mitochondrial and ER stress
response
The chemical composition and complexity predominantly depend
on the heating conditions, such as the temperature and the oxygen ﬂow.
During the combustion process of a cigarette, burning zone temperatures can reach 900 °C. The area behind marginal oxygen levels reaches
approximately 700 °C in the distillation zone, where pyrolytic reactions
occur. Inhaled smoke drawn through the cigarette is named mainstream
smoke. The smoldering end of the cigarette, which reaches approximately 800 °C by diﬀusion of oxygen has combustion conditions signiﬁcantly diﬀer from mainstream conditions [71].
Mainstream smoke consists of particle and gas phases, including
volatile organic compounds (VOC), and semi-volatile organic compounds (SVOC). Chemical classes that constitute tobacco smoke include
aldehydes, ketones, carboxylic acids, phenols, nitriles, alkaloids, and
various saturated and unsaturated hydrocarbons. Smoke constituents
can act as electrophiles, free radicals, and reactive anions. For example,
benzo[a]pyrene converts to quinone, which then produces ROS as byproducts. Hydroxyl ions, which is another crucial ROS, is also formed
by hydrogen peroxide via Fenton's reaction in the tar phase or by its
compounds such as catechol. Redox cycling mechanisms also form
semiquinones and superoxide ions, which are highly reactive. Gasphase components such as nitric dioxide can form carbon-centered radicals by reacting with other smoke constituents. Superoxide ions react
with nitric oxide to form peroxynitrite with high oxidizing capacity.
Peroxynitrite can also deplete intracellular antioxidants such as glutathione levels. Reactive oxygen and nitrogen species (ROS and RNS,
respectively) generated in mainstream smoke perpetually form reactive
intermediates such as acrolein, which are cytotoxic [72].
Vastly produced polycyclic aromatic hydrocarbon (PAH) components in tobacco smoke, such as 1-Nitropyrene, was shown to augment
mitochondrial genes and induce deregulation of mitochondrial genes
via C/EBPα [73]. Copious amounts of exogenous reactive oxygen and
nitrogen species produced in tobacco smoke oﬀset the redox homeostasis in cells inducing oxidative stress. ER stress can result in unfolded
protein response (UPR) in cells, including lung cells such as epithelial
cells. UPR can cause dissociation of ER signaling molecules such as
ATF6, Ire1, and PERK from GRP78/BiP. An increase in BiP is a hallmark
of UPR. Upregulation of these molecules induces chaperone assisted
folding and degradation of misfolded proteins. PERK activated eIF-2α
reduces protein synthesis and therefore preventing protein misfolding.
Nrf2, a bZIP protein that regulates antioxidant proteins, is often activated to counteract CS-induced oxidative stress and pathogenesis of
emphysema [74].
Nicotine is present in tobacco smoke, e-liquids, and heat-not-burn
products. Nicotine has shown to increase the phosphorylation of PERK
and eIF-2α. Nicotine was also shown to alter Hsd11b1 (11βHydroxysteroid dehydrogenase type 1), placental cell diﬀerentiation
and function marker. These eﬀects show the potential risks involved
with nicotine intake during pregnancy [75]. Another study has also
demonstrated an upregulation of ER stress markers (eI2α, Grp78, Arf4,
and CHOP) in rat placenta. Additional ER stress-inducing factor, impaired disulﬁde bond formation, was also observed in nicotine exposed
rat placenta, with decreased mRNA levels of protein-disulﬁde-isomerase (PDI) and oxidoreductase, QSOX1 [76]. Contrary to these
ﬁndings, Srinivasan et al. showed neuroprotective eﬀects of low-dose
nicotine by looking at nAChRs in dopaminergic neurons. They showed
nicotine reducing UPR and CHOP activation following ER stress-inducing, tunicamycin (Tu) treatment [77].
Zahedi et al. demonstrated that e-liquid aerosols cause mitochondrial stress in stem cells. Exposure of stem cells to e-cig aerosols showed
an increase in the presence of superoxide by MitoSOX. Moreover,
protein oxidation was observed along with the aggregation of
5
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proteins. Moreover, decrease mitochondrial ﬁssion gene expressions
(e.g., Fis1), and uncoupling genes contribute to reduced oxidative
phosphorylation (OXPHOS), Ucp2, Ucp3, and Ucp5, have also been
observed. These adverse eﬀects are from semivolatile and nonvolatile
organic compounds. Tobacco speciﬁc nitrosamines, nicotine, and related alkaloids are responsible constituents for mitochondrial stress
responses [72,89]. While these responses may be induced as a survival
mechanism, chronic thirdhand smoke may cause severe cytotoxicity
and apoptosis leading to pathogenesis as seen with stem cell exposures
in previous studies [90].
Tobacco smoke, including secondhand, thirdhand, e-cig aerosols,
and heated not burned or modiﬁed tobacco products release chemical
compounds that form ROS and RNS species. These products adversely
aﬀect cellular organelles, including mitochondria, endoplasmic reticulum, and Golgi apparatus. Exposure to cigarette smoke compounds
alters mitochondrial oxidative phosphorylation and metabolic activity,
which are symptoms of debilitating diseases such as COPD and asthma.
Molecular signatures of CS-induced stress include altered mitochondrial
biogenesis and mitophagy, increased mtDNA mutations, and damageassociated molecular patterns (DAMPs) are closely associated with lung
diseases, as discussed later. Overall, these ﬁndings on elevated mitochondrial dynamics and the quality control, essential for normal
physiological functions are disrupted by the CS-induced oxidative stress
(Fig. 2) and these pathways could be potential therapeutic targets
against smoking-related chronic lung diseases.

mitochondrial nucleoids and mitochondrial DNA damage. Furthermore,
this study attributed these mitochondrial stress responses to the nicotine present in e-liquids [78].
Tobacco smoke is well known to cause lung epithelial ciliary impairment. Smoke reduces the ciliary beat frequency, motility, and even
ciliary loss. Similarly, tobacco smoke has been shown to signiﬁcantly
alter the structure of mitochondria structure signiﬁcantly by altering
the microtubular network and reducing the matrix. Disruption of the
internal structure of the mitochondria is associated primarily with the
particulate phase of the tobacco smoke, although the gas phase (e.g.,
volatile phenolic fractions) induces mitochondrial swelling. These effects interfere with mitochondrial energy production, thus ciliary dysfunction [79].
E-liquids are available in a plethora of ﬂavors. These ﬂavors are
imparted by ﬂavoring chemicals. Cinnamaldehyde, used in cinnamonﬂavored e-liquids, have been shown to dysregulate mitochondria in
epithelial cells, thereby aﬀecting the ciliary beat function and cell
motility. Mitochondrial respiration, glycolysis, and ATP production
were signiﬁcantly aﬀected by cinnamaldehyde vapor. These adverse
eﬀects were caused by cinnamaldehyde and the nicotine content did
not contribute to these eﬀects. As cilia are an important defense mechanism in blocking foreign material into the respiratory system, cinnamaldehyde inhalation may increase the susceptibility to infections
[80]. Lerner et al. showed elevated mitochondrial ROS levels by exposure to short e-cig exposures, including CuO, Cu40, and Cu60 treatments, in human fetal lung ﬁbroblast (HFL-1) cells. This was also
supported by decreased COX-II levels demonstrating the vulnerability
of complex IV [81]. These studies show that exposure to e-cigarette and
e-liquid constituents causes mitochondrial stress in cells.
Aryl hydrocarbon receptor (AhR) agonists such as PAHs, i.e., benzo
[a]pyrene, can be detected in the serum of smokers. These ROS producing compounds induced the overexpression of autophagy proteins
BECN1 and LC3 and coupled with increased PARK2 pro-ﬁssion protein
for autophagosomal degradation and reduced mitofusin proteins, MFN1
and MFN2 [82]. These changes in protein expression suggest that CS
exposure gives rise to mitochondrial dysregulation and mitophagy.
Downregulation of mitofusin proteins has been debatable as some studies observed increased expression of MFN2 by CS exposure [83].
Regulation of expression of these proteins may be attributed to the
adaptive response to mitochondrial stress. Moreover, nontoxic doses of
cigarette smoke extract have shown unchanged HSP60 (mitoUPR) levels in alveolar epithelial cells [83].
Tobacco smoke also disrupts the trans-Golgi network, where Golgi
phosphoprotein 3 (GOLPH3) plays a vital role in protein traﬃcking and
glycosylation. GOLPH3 has been linked with ER in relation to phosphotidylinositol-4-phosphate signal termination mediated membrane
docking mechanism [84]. During mitochondrial biogenesis, GOLPH3
transits between Golgi and mitochondria, and the upregulation of
GOLPH3 causes mitochondrial dysfunction. Thus, nicotine derived nitrosamine ketones (NNKs) in tobacco smoke can dysregulate ER-Golgi
network [85]. Tobacco smoke induces mitochondrial DNA mutations,
i.e., point mutations, insertions, deletions. Secondhand smoke is considered to be more toxic than mainstream smoke. Undiluted sidestream
smoke yields more harmful constituents compared to the mainstream
per pound of smoke [86]. Sidestream smoke at 2 μg/mL is considered
toxic for the airway epithelium. Moreover, aged secondhand smoke has
been demonstrated to have increased total particulate matter, CO, and
nicotine concentrations and toxicity by several folds compared to the
mainstream smoke [87]. Neonatal secondhand smoke exposure has
shown to signiﬁcantly increase the mitochondrial superoxide dismutase
activity with increased oxidative stress, altered mitochondrial DNA
copy number, and deletion levels [88].
Exposure to thirdhand smoke extract has shown to cause cytotoxicity as well as altered mitochondrial morphology and function.
Increased mitochondrial hyperfusion, i.e., increased mitochondrial
membrane potential, increased superoxide production, and oxidation of

1.5. Mitochondrial dysfunction in HIV and CS-induced lung diseases
Lung diseases such as COPD, pulmonary hypertension, lung cancer,
and pneumonia are emerging as signiﬁcant comorbidities in the HIVinfected population. Combination antiretroviral therapy (cART) suppresses viral replication but is unable to eradicate HIV due to reactivation of the HIV from latently infected anatomical reservoirs
[91,92] upon cessation of cART [93–96]. There is convincing evidence
that the lungs are anatomical reservoirs of HIV [97–99]. HIV is found in
cell-free bronchoalveolar lavage ﬂuid [97], alveolar macrophages and
intrapulmonary lymphocytes [98,99]. HIV infection is an independent
risk factor for the development of COPD irrespective of the smoking
status [100]. The mechanism by which HIV promotes chronic inﬂammation predisposing to COPD is not known. HIV patients exhibit
increased oxidative stress [101,102]. HIV induces oxidative stress and
this has been attributed to several HIV proteins including HIV Tat, Nef,
Vpr and gp120 in diﬀerent cell types [103–105]. HIV infected cells are
known to express HIV proteins even in the presence of cART. Proteins
like, Tat and Nef are immediate early proteins of HIV and are not
suppressed by cART [106–110]. The protein transduction domain of Tat
allows its secretion by infected cells and uptake by bystander cells
where it mediates pleotropic eﬀects [111–114]. Likewise, Nef has been
secreted from cells via extracellular vesicles and exosomes [115,116].
HIV Nef has been shown be expressed in aviremic lungs [110]. We have
shown that primary bronchial epithelium cultured ex vivo and bronchial brushings from human subjects express canonical HIV receptors
CD4, CCR5, and CXCR4 receptors and can be infected with HIV [117].
We have also demonstrated that cigarette smoke (via TGF-β signaling)
increases levels of HIV receptors and facilitates HIV infection of bronchial epithelial cells, increasing the viral burden in the airway possibly
explaining worse outcomes in HIV smokers [118].
HIV infection of bronchial epithelial cells and secretion of viral
proteins can aﬀect mitochondrial homeostasis. Santerre et al., recently
demonstrated that HIV Nef induces the hyperpolarization of mitochondrial membrane as well as mitochondrial morphology causing
them to appear hyperfused when compared to Carbonyl cyanide 3chlorophenylhydrazone treated controls [119]. HIV Vpr has been
shown to decrease the mitochondrial membrane potential of CD4 Tcells and bystander cells leading to apoptosis [105]. While HIV Tat has
been shown to promote inﬂammation in cell lines as well as mouse
6
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Fig. 2. Potential therapeutic targets within the mitochondrial oxidative stress response pathways of the airway epithelium.

promote mitochondrial fragmentation in a ROS dependent manner,
consequently promoting senescence in primary human bronchial epithelial cells [20]. In this study, CSE-induced ROS was shown to posttranslationally modify DRP-1 resulting in its translocation to mitochondria followed by mitochondrial fragmentation.

models with secretion of proinﬂammatory cytokines [120,121], the
mechanism by which it promotes inﬂammation has not been determined. However, recent reports have demonstrated that HIV Tat
impairs mitochondrial homeostasis in diﬀerent cell types [122–124].
Tat expression in the airway epithelial cells or exposure to secreted Tat
by other immune cells in the airway can similarly aﬀect mitochondrial
homeostasis and promote epithelial cell senescence. In our laboratory
we have observed that HIV Tat alters the epithelial microRNAome to
suppress some of the key proteins in mitophagy and general macroautophagy with consequent impaired mitophagy and increased cellular
senescence in airway epithelial cells (unpublished data). An indirect
eﬀect of HIV infection on mitochondrial homeostasis is the use of antiretrovirals in controlling HIV. Many early reports have implicated cART
with mitochondrial dysfunction in pediatric patients as well as adults
[125], speciﬁcally with use of nucleoside reverse transcriptase inhibitors (NRTI). These have been attributed to a lack of speciﬁcity of
these inhibitors where they also target mitochondrial DNA leading to
decreased levels of mtDNA. Patients on twelve months of NRTI therapy
demonstrate decrease mitochondrial DNA [126].
Almost 60% of people living with HIV smoke tobacco [127]. Given
that cigarette smoke increases HIV gene expression [128] while also
upregulating HIV receptors on primary bronchial epithelial cells [118],
it is expected that mitochondrial dysfunction will be exacerbated in HIV
smokers compared to HIV non-smokers, consequently exacerbating senescence, inﬂammation, and lung aging. A number of reports, including
ours, have reported that cigarette smoke promotes mitochondrial dysfunction leading to epithelial cell senescence [14,18,20]. Cigarette
smoke inhibits Parkin translocation to damaged mitochondria resulting
in impaired mitophagy and senescence in mouse models of COPD as
well as in lungs of chronic smokers and COPD patients [18]. CS-impaired mitophagy was shown to accelerate lung aging in mouse models
of COPD [14]. In addition, IPF lung evaluation has shown that TGF-β1
induces mitochondrial fragmentation, ROS production and in fact increased PINK expression [129]. CS-impaired mitophagy could further
strengthen the debilitating eﬀects of IPF. Mitochondrial integrity itself
is aﬀected in COPD lung tissues and CS extract (CSE) was shown to

1.6. Mitochondrial DAMPs, noncoding RNAs and mucociliary clearance
mechanisms
Lung injury and other cellular stress described earlier could trigger
the release of mitochondrial damage-associated molecular patterns (mtDAMPs) into the cytosol or extracellular space [2,130] and activate the
innate lung responses via pattern recognition receptors (PRRs) [131].
To prevent the release of these proinﬂammatory molecules cells have
developed various defensive mechanisms including autophagosomal
degradation of the damaged mitochondria via mitophagy [2,3,17,132].
However, overwhelming injury or cellular stress releases these mtDAMPs or mitochondrial alarmins including mitochondrial DNA fragments (mtDNA), N-formyl peptides (fMLP), cardiolipin, succinate, ATP,
mitochondrial transcriptional factor A (TFAM) and the mitochondrial
antiviral signaling protein (MASP) [2,130]. These mtDAMPs bind to the
PRRs resulting in nuclear factor (NF)-κB- and MAPK-dependent proinﬂammatory response [133]. Accordingly, these pathways are intricately
regulated by several genetic and epigenetic factors. In addition, several
noncoding RNAs (ncRNAs) generated from the intergenic and intronic
regions have now been shown to regulate all stages of gene expression
and several cellular functions including the lung innate immune responses. Mucociliary clearance mechanisms are one of the primary innate defense mechanisms that physically clear the airways via mucociliary escalator [134,135]. In the respiratory tract, 9 genes have been
found to encode for mucins of which MUC2, MUC5AC, and MUC5B are
primarily found in airway secretions [136,137]. The heterogeneity in
airway mucins allows entrapment of many inhaled pathogens and
toxicants to help clear the airways by mucociliary clearance mechanisms, therefore, a lot of attention has been geared towards understanding the expression and the regulation of these mucins in the
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elevated mtDAMPs contribute to the development of COPD. It is noteworthy that mitochondria-targeted inhibitors suppressed the DAMPmediated radiation-induced lung tissue damage in a mouse model
[154]. Thus, substantial research eﬀorts are needed to develop an understanding of the role of ncRNA in the lung pathophysiologies speciﬁcally with regards to the regulation of mtDAMPs and mucociliary
clearance mechanisms.

context of lung pathologies.
The newly identiﬁed ncRNAs along with the well-characterized
proteins mediate an intricate crosstalk between mitochondria and the
nucleus to maintain the airway epithelial homeostasis. Among ncRNAs,
the small microRNAs (miRNAs or miRs) are implicated mainly in posttranscriptional gene regulation and a variety of innate immune processes but how these miRNAs are associated with the mitochondrial
homeostasis and mtDAMPs is still unknown. For example, in lung tissues, mtDAMPs induce the miR-223 expression that inhibits NLRP3
inﬂammasome and IL-1β release and suppressing miR-223 leads to the
activation of NLRP3-IL-1β and acute lung injury [138]. NLRP3 activators induce the release of the mitochondrial membrane lipid cardiolipin, another mtDAMP [139]. The miR-30a inhibited AECs-II apoptosis
by repressing the mitochondrial ﬁssion dependent on Drp-1 leading to
lung ﬁbrosis [140]. The miR-34/449 deﬁciency in ciliated cells results
in reduced cilia length and numbers, which is mediated, at least in part,
by the post-transcriptional repression of Cp110, a centriolar protein
suppressing cilia assembly [141], making these miRs indispensable for
mucociliary diﬀerentiation. Similarly, miR-183 was shown to be essential for hypercapnia responses by regulating isocitrate dehydrogenase 2 (IDH2) that impairs mitochondrial function and cell as
observed in patients with chronic lung diseases [142]. Strikingly, miR449a is upregulated by more than 1000-fold when epithelial cells from
human airways are lifted from a liquid environment to air, allowing
them to undergo mucociliary diﬀerentiation [143]. Among the mucin
expression regulation, miR-134-5p, miR-146a-5p, and let-7 family of
miRs have been shown to regulate chronic mucus hypersecretion associated with COPD [144]. Earlier, Pandit et al. (2010) reported that
the let-7d miR was associated with IPF, suggesting a potential therapeutic target for controlling IPF associated pathologies [145]. Similarly, miR-21 levels had also been found signiﬁcantly upregulated in
IPF and increased miR-21 levels promoted the TGF-β1 activty [146].
Furthermore, miR-145-5p was recently implicated in modulating TGFβ1 levels and could be useful therapeutic target in restoring the airway
epithelial homeostasis [147].
The other major species of ncRNAs are long ncRNAs (lncRNAs) that
are > 200 bases long with characteristic 3D structures and are involved
in the regulation of gene expression and several disease conditions.
Nevertheless, not much is known about the role of lncRNAs in
mtDAMPs and MCC mechanisms associated with lung pathophysiologies. Most lncRNAs that are transcribed in the nucleus also reside in
mitochondria and play a key role in regulating mitochondrial responses. For example, lncRNA RMRP or mitochondrial RNA-processing
endoribonuclease is required for mitochondrial DNA replication and
RNA processing, and the lncRNA SRA or steroid receptor RNA activator
is a key modulator of hormone signaling found in both mitochondria
and nucleus. The mitochondrial DNA also encodes for a set of lncRNAs
like lncND5, lncND6, and lncCyt b RNA encoded on the complementary
strands of ND5, ND6 and Cyt b genes as reviewed recently [148]. These
mitochondrial DNA-encoded lncRNAs also appear to function in the
nucleus and the molecular mechanisms underlying traﬃcking of the
mitochondrial-encoded lncRNAs to the nucleus are now beginning to
emerge [148]. There is also growing evidence towards mitochondria
importing the cytosolic ncRNAs via yet-to-be discovered mechanisms
[149].
The cellular DAMPs play a pivotal role in COPD pathogenesis with
several of them signiﬁcantly elevated in the lung tissues and blood
circulation of COPD patients compared to both smoking and nonsmoking controls [150,151]. Moreover, during COPD exacerbations,
the RAGE ligands like HMGB1, S100A8, and LL-37 are reportedly elevated [152]. These pathological ﬁndings have been successfully recapitulated in mouse models with most of the cellular DAMPs like galectin-3, S100A9, and dsDNA secreted into the inﬂamed airway tissues
following CS exposure in susceptible mice [151,153]. However, studies
are needed to ascertain whether the airway tissue of COPD patients is
predisposed to release mtDAMPs upon lung injury and whether

1.7. Mitochondria, stem cells, and aging lung diseases
Human lungs comprise of 40 diﬀerent types of cells or even more,
share to form the structure and physiological function [155]. Among
them, the lung stem cells are responsible for regenerating new tissues
and repair injury. Mitochondria are energy storehouses that produce
ATP through oxidative phosphorylation (OXPHOS). There are extensive
studies that demonstrated the important role of mitochondria in the
regulation of stem cell function. It also plays an important role in cell
signaling and any mitochondrial stress can generate ROS in stem cells.
Alteration in mitochondrial function of stem cells from various organspeciﬁc cells may produce age-related changes in self-renewal and
diﬀerentiation. The stem cells originating from diﬀerent organs have
diverse metabolic properties, the majority of stem cells use the glycolytic pathway of metabolism such as human and murine hematopoietic
stem cells, murine neural stem cells, human embryonic stem cells, and
mesenchymal stem cells [156–161]. The glycolytic pathway of respiration helps in maintenance of self-renewal and diﬀerentiation of
stem cells. These stem cells have low rate of mitochondrial oxidative
respiration. Though the stem cells require glycolytic pathway for selfrenewal, the oxidative pathway of respiration is required for diﬀerentiation [162,163]. The decline in function of mitochondria in stem
cells leads to alteration in stem cell functions and self-renewal and
aging [164–166].
The stem cells are required to diﬀerentiate and self-renew for the
maintenance of homeostasis of the various organs in the body. Exposure
to these agents or conditions leads to exhaustion of the stem cells and
unable to cope up with the requirement of various cell types in the
organs and develop age-related diseases [167–169]. Recently, several
types of stem cells have been reported in the lungs with the self-renewal
and diﬀerentiation properties that included tracheal club cells (clara
cells) and alveolar type II epithelial cells. The alveolar type II cells
diﬀerentiate to alveolar type I cells [170–172]. The altered function of
basal cells, endothelial progenitor cells, and hematopoietic stem cells
have been reported in smokers and COPD patients [173–175]. Additional studies have been reported showing altered function of mesenchymal stem cells in experimental mouse models [176,177]. Studies
have shown that stem cell exhaustion, alveolar epithelial cell injury and
hyperplasia are associated with pulmonary ﬁbrosis [178–182]. A decline in mitochondrial functions has been associated with age-dependent abnormal function of organs in experimental mouse models
[183,184].
Aging causes many structural and functional changes in the lungs,
such as enlarged alveoli, reduced surface area of gas exchange, loss of
alveolar attachment, reduced elastic recoil, and increased gas trapping
[185,186]. Aging is also associated with increased incidence of COPD
and IPF [187,188]. However, the cellular and molecular mechanisms of
occurrence of these diseases are still unknown. There are several mechanisms have been postulated by many researchers in the last several
years. The age-associated changes in oxidative stress, telomerase
length, immune functions, extracellular matrix, and anti-aging molecules, have been reported [189]. There is increased oxidative stress
observed in lungs and oxidative damage to mtDNA in skeletal muscle
cells of COPD patients [190,191]. Changes in telomere length reported
in former smokers, COPD and IPF patients [192,193]. Additionally,
increased incidence of infections and autoimmune diseases reported in
aging populations [194]. The alveolar structure is composed of collagen
and elastin proteins in extracellular matrix (ECM). Aging causes
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reported that the ratio of mtDNA and nDNA, could serve as an eﬀective
biomarker to identify COPD, asthma, and asthma-COPD overlap syndrome (ACOS) [216]. In addition, they report that higher content of
mtDNA is closely associated with COPD than asthma in ACOS patients
[217]. Similarly, Liu et al. reported that lower mtDNA copy number in
leukocyte was found associated with COPD patient compared to healthy
control [218]. Bindu et al. demonstrated SIRT3 serves as a protector of
mtDNA damage and prevents the pathogenesis of pulmonary ﬁbrosis
and myoﬁbroblast diﬀerentiation but not in COPD and asthma [219].
These studies nonetheless suggest that mtDNA can be a marker of
chronic lung disease or can be a therapeutic target for dysregulated
mitochondrial associated diseases.
Mitochondrial ROS is generated as a by-product of biosynthesis and
is probably responsible for the upregulated ROS level in patients with
chronic lung diseases. For instance, Hecker et al. reported that ROS
related markers: NADPH oxidase-4 (Nox4) and Nrf2 were protective
against IPF in a mouse model [220]. Nox4 acts as a sensor and checkpoint for metabolic/energetic process in mitochondria, and is, therefore, proposed as a novel intervention strategy to minimize the drugresistance in cancer [221]. CS exposure is associated with fragmented
mitochondria and mtROS generation, and COPD patients had smaller
size mitochondria compared to the healthy controls [20]. The mtROS
induced dysregulation of mitochondrial ﬁssion and fusion proteins (Fis1
and Drp1) aﬀect the mitochondrial dynamics in human bronchial epithelial cells [20]. Interestingly, long-term CS exposed BEAS-2B cells
presented only increased optic atrophy 1/mitochondrial dynamin-like
GTPase (OPA1) at a relatively higher concentration, while other mitochondrial ﬁssion/fusion proteins (Mfn1, Mfn2, Fis1, and Drp1) and
TFAM remained unchanged [222]. These studies indicate that in addition to causing a direct lung injury, CS exposure could induce mtROS
production and induce mitochondrial dysregulation.
Besides mitochondrial ﬁssion/fusion proteins, there are several
proteins involved in mitochondrial dysfunction associated chronic lung
diseases, such as PINK-Parkin, which are required for mitochondrial
degradation via mitophagy; or PPARγ coactivator-1 (PGC-1α/β) which
are responsible for mitochondrial biogenesis to maintain cellular energetics [16]. Recently, Yu et al. reported that resistance to IPF in a
mouse model is dependent on the intact PGC-1α, and PINK1 pathways,
because knocking down either of these pathways resulted in the development of IPF-like conditions [19]. In the pulmonary arterial smooth
muscle cells lacking sirtuin-1 and -3 (SIRT-1 and -3) or PGC-1α, the
mitochondrial biogenesis and dynamics were suppressed resulting in
reduced mtDNA content [223]. SIRT family of proteins, as discussed
before, are well-known in aging-related chronic lung diseases, such as
COPD and IPF [224]. Interestingly, although the preventing mitochondrial biogenesis by regulating PGC-1α/β is beneﬁcial in IPF a
similar mechanism induces cellular aging in COPD [16].
In addition, damaged mitochondrial accumulation was found in
COPD lungs, which might be due to the ineﬀective mitophagy [20]. The
appropriate removal of the damaged mitochondria is vital because
mitophagy can help to protect organs from injury caused by dysregulated mtROS and mtDNA release, which could cause inﬂammation and
apoptosis [225,226]. Previous reports have been discussed that damaged mitochondria were found in COPD lung tissues along with the
lower level of PARK2, which indicated that ineﬀective mitophagy was
associated with COPD pathogenesis [16,227,228]. The deﬁciency of
PINK1-PARK2 induced myoﬁbroblast diﬀerentiation and proliferation,
which are associated with IPF pathogenesis [229]. Moreover, TGF-β
treatment inhibited the expression of PINK1 and consequently promoted IPF [230].

changes in ECM, which leads to decline in lung function [186,195].
Further, changes in several anti-aging molecules reported in aging
conditions such as klotho gene, senescence marker protein-30, and
SIRT-1. The SIRT-1 expression was suppressed in the lungs of cigarette
smoke-exposed rats and in the lung cells from COPD patients
[196–199].
Recently, stem cell therapy initiated in human and experimental
models of acute lung injury and chronic diseases. There was some
success achieved in acute lung injury models. However, human trials
done recently were mostly unsuccessful in COPD patients. We have
recently shown that exosomes-derived from MSCs restore cigarette
smoke-induced lung abnormalities via attenuating mitochondrial
function [200].
The regenerative therapy attempted recently using two approaches.
The extrinsic approach by infusion of exogenous stem cells to repair the
damaged structures of the lungs using embryonic stem cells, induced
pluripotent stem cells, mesenchymal stem cells, and human lung stem
cells. The second approach intrinsic therapy was done by administering
the small molecule to stimulate the endogenous lung stem/progenitor
cells to repair the damaged tissues using retinoid compounds
[201–203].
1.8. Mitochondria, telomeres, and telosome/shelterin complex crosstalk
Perinuclear mitochondrial accumulation or clustering transmits a
nuclear signal via mtROS. Oxidative and genotoxic stress are wellknown initiators of telomere dysfunction. We have shown that CS
treatment causes perinuclear mitochondria clustering along with nuclear ROS accumulation and DNA damage foci formation, as well as
injurious lung responses [204].
Telomeres have specialized nucleoprotein structures that protect or
“cap” the linear ends of eukaryotic chromosomes from DNA repair,
preventing aberrant repair and end-to-end chromosome fusions.
Telomeres constitute TTAGGG DNA tandem repeats that are bound to a
multiprotein complex called shelterin/telosome that contains six vital
proteins TRF1, TRF2, POT1 (POT1a and POT1b in mouse), TPP1 (ACD/
TPP1 i.e. shelterin component TPP1), TIN2 and RAP1. Telomere loop
formation by TRF2 protects its ends from recognition by DNA damage
pathways. Telomere shortening is associated with aging, and current
studies suggest an important role of telomere structure/organization,
telomeric DNA damage, and telomere end-capping proteins during
aging and in various age-associated disorders. Mitochondrial dysfunction and telomere attrition may be involved in cellular senescence. This
may be due to TIN2 (shelterin protein) localization into mitochondria
apart from its nuclear compartment, leading to mitochondrial dysfunction [2].
CS treatment causes translocation and mitochondrial localization of
TIN2 in human lung cells [2]. A close correlation between perinuclear
mitochondria and telomeric DNA damage foci is observed in the presence of CS treatment. Furthermore, CS treatment causes telomere
shortening and shelterin TPP1 reduction in lung epithelial cells and
ﬁbroblasts. The precise mechanisms on how mitochondria coordinate
with shelterin telomeres to regulate CS-induced lung injurious responses are not known.
1.9. Dysregulated mitochondrial DNA and proteins in chronic lung diseases
As discussed before, mitochondria play a vital role in cell fate, differentiation, and disease pathogenesis [205–207], thus, mitochondrial
dysfunction aﬀects almost all the organs, such as liver, heart, kidney,
brain, and lungs [208–212]. Because mitochondria are major producers
of ROS, the mtDNA are at a higher risk of injury than nuclear DNA
(nDNA) because the histone-shield and the self-repair ability are absent
in mitochondria [213–215]. In this section, we focus on the mitochondrial targets (nucleic acids or protein markers) speciﬁcally associated with chronic lung diseases. Recently, Carpagnano et al.

1.10. Therapeutic potential of mitochondria transfer: role of Miro1
Recent studies have highlighted a strong translational and therapeutic potential of mitochondrial transfer, particularly in diseases associated with mitochondrial abnormalities/dysfunction. Particularly
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relevant are the data suggesting that mitochondrial transfer can rejuvenate cellular respiration. It has been shown that mitochondrial
transport machinery including mitochondrial Rho-GTPase 1 (Miro1)
regulates intracellular mitochondria movement and transfer of mitochondria between cells that occur via tunneling nanotubes and enhances MSC rescue eﬃcacy. A recent study found that the defects in
mitochondrial motility and distribution due to Miro1 deﬁciency are
enough to cause neurological disease, also implicating in CS-induced
lung inﬂammation [231]. This strategy provides a promising translational therapeutic tool for mitochondria transfer in conditions including
the response to CS exposure, where mitochondria are dysfunctional. We
have shown that bone marrow-MSCs form intercellular tunneling nanotubes and transfer their healthy mitochondria into lung epithelial
cells treated with CSE. We reveal the mechanisms by which the mitochondria are transferred into lung epithelial cells containing dysfunctional mitochondria in COPD/emphysema, and whether Miro1mediated mitochondrial transfer protects against emphysema in a
mouse model reverses the injuries.
1.11. Iron deﬁciency as a comorbidity to chronic pulmonary disease
Chronic pulmonary diseases and other chronic inﬂammatory conditions are associated with the iron deﬁciency and related comorbidities. In fact, Nickol et al. (2015) found that 18% of COPD patients had a
non-anemic functional iron deﬁciency versus only 5% of healthy adults
[232]. This comorbidity is due to cytokine stimulation of hepcidin expression in monocytes, macrophages, hepatocytes and various other
cells leading to iron trapping within those cells and a functional iron
deﬁciency [233,234]. However, Cloonan et al. (2016) have shown that
intracellular iron metabolism may in fact be an important factor in
COPD pathogenesis [235]. They have identiﬁed a pathway in which the
iron-responsive element-binding protein 2 (IRP2) increases the expression of mitochondrial cytochrome c oxidase 1 (COX-1), a terminal
electron acceptor in the process of oxidative phosphorylation, which
has a proposed role as a regulator of mitochondrial iron metabolism
[236]. IRP2 therefore leads to an increased iron load in mitochondria,
which seems to have a highly detrimental eﬀect, for as Cloonan et al.
(2016) have shown, IRP2−/− mice are signiﬁcantly less susceptible to
chronic CS-induced pulmonary injury, changes in mucociliary clearance, and most importantly, mitochondrial aberrations such as cytochrome c release, decrease in mitochondrial membrane potential and
mitochondrial ROS generation. Although the extent of the role that
mitochondrial iron loading may have on COPD pathogenesis is not
clearly established, further studies on the iron-induced mitochondrial
stress responses and potential therapeutic targeting may be highly
beneﬁcial.

Fig. 3. Chronic exposures to direct or indirect tobacco smoke or vapors from
electronic cigarettes induce molecular dysregulation in mitochondria, ER, and
Golgi apparatus that leads to pathologic conditions observed in COPD and IPF.

CS and e-liquid aerosols induce a signiﬁcant mitochondrial superoxide increase, respiration reduction, and aﬀect ciliary function.
Evidence suggests an increase in autophagy (increased BECN1 and LC3)
however a signiﬁcant decrease in mitophagy as heavily fragmented and
damaged mitochondria with low membrane potentials are observed.
Few signiﬁcant changes in fusion/ﬁssion proteins have been reported.
In COPD, increased mitochondrial biogenesis through Golph3 seems to
have a detrimental eﬀect. Oxidative stress and reduced mitophagy lead
to the release of mtDAMPs and initiation of both intra and extracellular
inﬂammatory pathways. In all discussed chronic pulmonary conditions,
an increase in mitophagy via the PINK/Parkin pathway would remove
damaged mitochondria and alleviate the condition. Additional factors,
such as non-coding RNAs play an increasingly pivotal role and provide
a unique therapeutic opportunity; however, extensive further research
is required. Modulation of miR-223, 30, 449a, 34/449 and 183 can
regulate inﬂammatory response, mucociliary diﬀerentiation, and
chronic mucous secretion.
There is evidence that concomitant viral infection (e.g., HIV) and CS
exposure further augment oxidative stress leading to release of cellular
DAMPs and induce cellular senescence. Thus, the airway mucosal viral
infection, DAMPs accumulation, and cellular senescence aggravate the
ongoing inﬂammatory and lung pathologic responses (Fig. 4). In case of
HIV infection, the HIV Vpr has been shown to decrease mitochondrial
membrane potential and induce apoptosis. Concomitant exposure additionally reduces the level of mitophagy, and CS increases HIV receptor levels and facilitates HIV infection.
Chronic pulmonary pathology is commonly age-related, and loss of
stem cells plays a pivotal role. The conversion from glycolysis to
OXPHOS is crucial for stem cell diﬀerentiation, and as such, loss of
mitochondrial quality control reduces tissue regenerative and repair
capability and leads to faster pulmonary aging. Mitochondrial DNA
damage and telomere reduction have also been reported in COPD patients, along with reduced anti-aging molecules such as the klotho gene,
senescence marker 30 and SIRT1. Therapeutic induction of these genes
would signiﬁcantly improve care, especially since recent stem cell or
exosome treatments have been unsuccessful in COPD patients.
Finally, increasing evidence has shown that the molecular clock
plays a quintessential role. ATF4 was shown to be a transcription factor
for CLOCK and oncogenic PERK expression was shown to reduce

2. Conclusions
Chronic pulmonary diseases, including COPD and IPF, present with
similar cellular pathophysiology. There is a signiﬁcant increase in ROS/
RNS and cellular redox conditions involved in the pathology of mitochondrial dysfunction and senescence. The subcellular interaction
between the rough ER, mitochondria, and Golgi apparatus is disrupted
leading to dysregulated UPR and oxidative stress responses leading to
chronic pathologic conditions (Fig. 3). CS coupled with viral or aging
insults induces protein misfolding and protein inﬂux into the ER,
overburdening the primary chaperones (GRP78, PDI, calnexin, and
calreticulin), thus initiating the UPR. Ample evidence supports the activation of the PERK, IRE1, and ATF6 pathways downstream of GRP78
delocalization. Increased induction of chaperones or GRP78 or deactivation/degradation of UPR downstream components would signiﬁcantly alleviate pulmonary injury. Additionally, the delivery of ROS
scavengers to the appropriate location or any reduction of the CS-induced ROS may profoundly improve chronic pulmonary disease outcomes.
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Fig. 4. Viral infection, DAMPs, and cellular senescence of airway epithelium aggravate the ongoing inﬂammatory and pathologic responses.
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Negative Regulatory Factor
NLRP3 nucleotide-binding domain, leucine-rich repeat Pyrin
Domain Containing 3
NRT1
nucleoside reverse transcriptase inhibitors
OPA1
optic atrophy 1/mitochondrial dynamin-like GTPase
OXPHOS oxidative phosphorylation
PAH
polycyclic aromatic hydrocarbons
PDI
protein disulﬁde isomerase
PER
period
PERK
protein kinase RNA (PKR)-like ER kinase
Pink1
PTEN-induced putative kinase 1
POT1
Protection Of Telomeres 1
QSOX1 quiescin sulfhydryl oxidase 1
RAP1
Repressor/Activator Protein 1
RNS
Reactive nitrogen species
ROS
reactive oxygen species
SVOC
semi-volatile organic compounds
Tat
Trans-Activator of Transcription
TGF
β1 transforming growth factor beta-1
TIN2
TRF1- and 2-Interacting Nuclear Protein 2
TRFs
Telomeric Repeat Factors
UPR
unfolded protein response
Volatile organic compounds
VOC
Vpr
Viral Protein R
XBP1
X-box binding protein 1

BMAL1 expression. Both ATF4 and PERK induce miR-211 and induced
GRP78 overexpression increases the amplitude of circadian protein
oscillations. The molecular clock genes require investigation for therapeutic potential, like melatonin, which was found reduced in COPD
patients, reduced oxidative stress and increased SIRT1 expression.
Overall, CS-induced oxidative stress, mitochondrial dysfunction, circadian rhythm, aging and cellular senescence mediated ER stress are involved in the pathogenesis of chornic lung diseases. Targeting the
speciﬁc ER-mitochondria redox signaling events may provide novel
therapeutic strategies which would be more beneﬁcial in managing
chronic lung diseases.
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